α-Diimines as Versatile, Derivatizable Ligands in Ruthenium(II) p-Cymene Anticancer Complexes

被引:58
|
作者
Biancalana, Lorenzo [1 ]
Batchelor, Lucinda K. [2 ]
Funaioli, Tiziana [1 ]
Zacchini, Stefano [3 ]
Bortoluzzi, Marco [4 ]
Pampaloni, Guido [1 ]
Dyson, Paul J. [2 ]
Marchetti, Fabio [1 ]
机构
[1] Univ Pisa, Dipartimento Chim & Chim Ind, Via G Moruzzi 13, I-56124 Pisa, Italy
[2] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland
[3] Univ Bologna, Dipartimento Chim Ind Toso Montanari, Viale Risorgimento 4, I-40136 Bologna, Italy
[4] Univ Ca Foscari Venezia, Dipartirnento Sci Mol & Nanosistemi, Via Torino 155, I-30170 Venice, Italy
基金
瑞士国家科学基金会;
关键词
INHIBITOR VALPROIC ACID; ARENE COMPLEXES; HUMAN OVARIAN; IN-VITRO; CONDUCTIVITY MEASUREMENTS; GLYOXAL DERIVATIVES; COORDINATION MODES; ANTITUMOR-ACTIVITY; PHASE I; METAL;
D O I
10.1021/acs.inorgchem.8b00882
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
alpha-Diimines are among the most robust and versatile ligands available in synthetic coordination chemistry, possessing finely tunable steric and electronic properties. A series of novel cationic ruthenium(II) p-cymene complexes bearing simple a-diimine ligands, [(eta(6)-p-cymene)RuCl{kappa N-2-(HCNR)(2)}]NO3 (R = Cy, [1]NO3; R = 4-C6H10OH, [2]NO3; R = 4-C6H4OH, [3]NO3), were prepared in near-quantitative yields as their nitrate salts. [2]NO3 displays high water solubility. The potential of the a-diimine ligand in [3]NO3 as a carrier of bioactive molecules was investigated via esterification reactions with the hydroxyl groups. Thus, the double-functionalized derivatives [(eta(6)-p-cymene)RuCl{kappa N-2-(HCN(4-C6H4OCO-R))(2})]NO3 (R = aspirinate, [5]NO3; valproate, [6]NO3) and also [4]Cl (R = Me) were obtained in good-to-high yields. UV-vis and multinuclear NMR spectroscopy and cyclic voltammetric studies in aqueous solution revealed only minor ruthenium chloride hydrolytic cleavage, biologically accessible reduction potentials, and pH-dependent behavior of [3]NO3. Density functional theory analysis was performed in order to compare the Ru-Cl bond strength in [1](+) with the analogous ethylenediamine complex, showing that the higher stability observed in the former is related to the electron-withdrawing properties of the adiimine ligand. In vitro cytotoxicity studies were performed against tumorigenic (A2780 and A2780cisR) and nontumorigenic (HEK-293) cell lines, with the complexes bearing simple a-diimine ligands ranging from inactive to IC50 values in the low micromolar range. The complexes functionalized with bioactive components, i.e., [5]NO3 and [6]NO3, exhibited a marked increase in the cytotoxicity with respect to the precursor [3]NO3.
引用
收藏
页码:6669 / 6685
页数:17
相关论文
共 50 条
  • [31] Synthesis, Characterization and Cytotoxicity of (.6-p- cymene) ruthenium(II) Complexes of a- Amino Acids
    Egbewande, Folake A.
    Paul, Lydia E. H.
    Therrien, Bruno
    Furrer, Julien
    EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2014, 2014 (07) : 1174 - 1184
  • [32] Multinuclear ruthenium(II) complexes as anticancer agents
    Gorle, Anil K.
    Ammit, Alaina J.
    Wallace, Lynne
    Keene, F. Richard
    Collins, J. Grant
    NEW JOURNAL OF CHEMISTRY, 2014, 38 (09) : 4049 - 4059
  • [33] Physicochemical Studies and Anticancer Potency of Ruthenium η6-p-Cymene Complexes Containing Antibacterial Quinolones
    Kljun, Jakob
    Bytzek, Anna K.
    Kandioller, Wolfgang
    Bartel, Caroline
    Jakupec, Michael A.
    Hartinger, Christian G.
    Keppler, Bernhard K.
    Turel, Iztok
    ORGANOMETALLICS, 2011, 30 (09) : 2506 - 2512
  • [34] Enhanced anticancer activity of half-sandwich Ru(II)-p-cymene complex bearing heterocyclic hydrazone ligand
    Haribabu, Jebiti
    Srividya, Swaminathan
    Umapathi, Reddicherla
    Gayathri, Dasararaju
    Venkatesu, Pannuru
    Bhuvanesh, Nattamai
    Karvembu, Ramasamy
    INORGANIC CHEMISTRY COMMUNICATIONS, 2020, 119
  • [35] In vitro studies on the selective cytotoxic effect of luminescent Ru(II)-p-cymene complexes of imidazo-pyridine and imidazo quinoline ligands
    Selvam, Pravinkumar
    De, Sourav
    Paira, Priyankar
    Kumar, S. K. Ashok
    Kumar, Selva R.
    Moorthy, Anbalagan
    Ghosh, Arjita
    Kuo, Yung-Chih
    Banerjee, Subhasis
    Jenifer, Shantha Kumar
    DALTON TRANSACTIONS, 2022, 51 (45) : 17263 - 17276
  • [36] Half-sandwich ruthenium (II) p-cymene complexes based on organophosphorus ligands: Structure determination, computational investigation, in vitro antiproliferative effect in breast cancer cells and antimicrobial activity
    Klaimanee, Ekkapong
    Nhukeaw, Tidarat
    Saithong, Saowanit
    Ratanaphan, Adisorn
    Phongpaichit, Souwalak
    Tantirungrotechai, Yuthana
    Leesakul, Nararak
    POLYHEDRON, 2021, 204
  • [37] Ruthenium(II) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies
    Bhattacharyya, Sudipta
    Purkait, Kallol
    Mukherjee, Arindam
    DALTON TRANSACTIONS, 2017, 46 (26) : 8539 - 8554
  • [38] Chemotherapeutic Activities of New η6-p-Cymene Ruthenium(II) and Osmium(II) Complexes with Chelating SS and Tridentate SNS Ligands
    Ywaya, David O.
    Ibrahim, Halliru
    Friedrich, Holger B.
    Bala, Muhammad D.
    Soobramoney, Lynette
    Daniels, Aliscia
    Singh, Moganavelli
    MOLECULES, 2024, 29 (05):
  • [39] Anticancer ruthenium(II) tris(pyrazolyl)methane complexes with bioactive co-ligands
    Gobbo, Alberto
    Pereira, Sarah A. P.
    Biancalana, Lorenzo
    Zacchini, Stefano
    Saraiva, M. Lucia M. F. S.
    Dyson, Paul J.
    Marchetti, Fabio
    DALTON TRANSACTIONS, 2022, 51 (44) : 17050 - 17063
  • [40] Neutral p-cymene ruthenium complexes with P-stereogenic monophosphines. New catalytic precursors in enantioselective transfer hydrogenation and cyclopropanation
    Grabulosa, Arnald
    Mannu, Alberto
    Mezzetti, Antonio
    Muller, Guillermo
    JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2012, 696 (26) : 4221 - 4228